Literature DB >> 17520709

Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951-2000.

D Fitzsimmons1, C Osmond, S George, C D Johnson.   

Abstract

BACKGROUND: The aim of this study was to describe period and cohort effects in incidence and mortality of stomach and pancreatic cancer in England and Wales.
METHODS: National figures for mortality (1951-2000) and incidence (1971-2000) were analysed using log-linear Poisson regression models to obtain relative risks (RR) for period (year of incidence or death) and cohort (year of birth).
RESULTS: Stomach cancer shows a pronounced cohort effect in mortality with a decline in RR in men from 2.20 (1876) to 0.47 (1946) and a reduction from 2.79 to 0.41 for women. Mortality to incidence ratios are now less than 0.70. Pancreatic cancer mortality (men) RR rose from 0.91 (1951-1955) to a peak 1.11 (1976-1980) and then declined to 0.90 (1996-2000). Women showed a similar pattern. Cohort RR (men) increased to a peak of 1.14 in 1916 and declined to 1.01 in 1946, and continued to fall; the peak occurred slightly later in women. Mortality to incidence ratios were near 1 in the first 20 years, declining to 0.95 in the last 10 years.
CONCLUSION: Stomach cancer incidence has fallen continuously from 19(th) century birth cohorts onwards. Incidence of pancreatic cancer has fallen in successive birth cohorts after 1920; peak period risk was 1976-1990. Age-standardized mortality and case mortality for pancreatic cancer are declining. Copyright (c) 2007 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17520709     DOI: 10.1002/bjs.5751

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

1.  Study of risk factors for gastric cancer by populational databases analysis.

Authors:  Fangio Ferrari; Marco Antonio Moura Reis
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

2.  Presentation and Survival of Gastric Cancer Patients at an Urban Academic Safety-Net Hospital.

Authors:  Ryan Morgan; Michael Cassidy; Susanna W L DeGeus; Jennifer Tseng; David McAneny; Teviah Sachs
Journal:  J Gastrointest Surg       Date:  2018-08-10       Impact factor: 3.452

Review 3.  Development of an integrated pancreatic disease service.

Authors:  James A Jupp; Colin D Johnson; Fanny W Shek; David R Fine
Journal:  Frontline Gastroenterol       Date:  2011-01-09

Review 4.  Proteinase activated-receptors-associated signaling in the control of gastric cancer.

Authors:  Silvia Sedda; Irene Marafini; Roberta Caruso; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

5.  The decline in stomach cancer mortality: exploration of future trends in seven European countries.

Authors:  Masoud Amiri; Fanny Janssen; Anton E Kunst
Journal:  Eur J Epidemiol       Date:  2010-11-18       Impact factor: 8.082

6.  Analysis of mortality rates for pancreatic cancer across the world.

Authors:  D Hariharan; A Saied; H M Kocher
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

7.  Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia.

Authors:  Christian Felley; Hanifa Bouzourene; Marianne Bründler G VanMelle; Antoine Hadengue; Pierre Michetti; Gian Dorta; Laurent Spahr; Emiliano Giostra; Jean Louis Frossard
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

8.  Stomach cancer mortality in the future: where are we going?

Authors:  Masoud Amiri
Journal:  Int J Prev Med       Date:  2011-04

9.  Depressive disorders among patients with gastric cancer in Taiwan: a nationwide population-based study.

Authors:  Li-Yu Hu; Chia-Jen Liu; Chiu-Mei Yeh; Ti Lu; Yu-Wen Hu; Tzeng-Ji Chen; Pan-Ming Chen; Shyh-Chyang Lee; Cheng-Ho Chang
Journal:  BMC Psychiatry       Date:  2018-09-03       Impact factor: 3.630

10.  The survival and the long-term trends of patients with gastric cancer in Shanghai, China.

Authors:  Leizhen Zheng; Chunxiao Wu; Pan Xi; Meiling Zhu; Li Zhang; Siyu Chen; Xiaoping Li; Jianchun Gu; Ying Zheng
Journal:  BMC Cancer       Date:  2014-04-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.